These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 3489519)

  • 1. Lack of production of interleukin 1 by human blood monocytes activated to the antitumor state by liposome-encapsulated muramyl tripeptide.
    Tandon P; Utsugi T; Sone S
    Cancer Res; 1986 Oct; 46(10):5039-44. PubMed ID: 3489519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dried preparation of liposomes containing muramyl tripeptide phosphatidylethanolamine as a potent activator of human blood monocytes to the antitumor state.
    Sone S; Utsugi T; Tandon P; Ogawara M
    Cancer Immunol Immunother; 1986; 22(3):191-6. PubMed ID: 3731204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative interaction of free and liposome-encapsulated nor-muramyl dipeptide or muramyl tripeptide phosphatidylethanolamine (3H-labelled) with human blood monocytes.
    Fogler WE; Fidler IJ
    Int J Immunopharmacol; 1987; 9(2):141-50. PubMed ID: 3583507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muramyl tripeptide phosphatidylethanolamine encapsulated in liposomes stimulates monocyte production of tumor necrosis factor and interleukin-1 in vitro.
    Maeda M; Knowles RD; Kleinerman ES
    Cancer Commun; 1991; 3(10-11):313-21. PubMed ID: 1722107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal muramyl tripeptide up-regulates interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-8 gene expression in human monocytes.
    Asano T; McWatters A; An T; Matsushima K; Kleinerman ES
    J Pharmacol Exp Ther; 1994 Feb; 268(2):1032-9. PubMed ID: 8113959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiating effect of muramyl dipeptide and its lipophilic analog encapsulated in liposomes on tumor cell killing by human monocytes.
    Sone S; Mutsuura S; Ogawara M; Tsubura E
    J Immunol; 1984 Apr; 132(4):2105-10. PubMed ID: 6699409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of tumoricidal properties in human blood monocytes by liposomes containing lipophilic muramyl tripeptide.
    Kleinerman ES; Erickson KL; Schroit AJ; Fogler WE; Fidler IJ
    Cancer Res; 1983 May; 43(5):2010-4. PubMed ID: 6831430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-(tumor necrosis factor) alters the response of human monocytes to liposomal muramyl tripeptide.
    Maeda M; Asano T; Kleinerman ES
    Cancer Immunol Immunother; 1993 Aug; 37(3):203-8. PubMed ID: 8334682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor cytotoxicity and interleukin 1 production of blood monocytes of lung cancer patients.
    Sone S; Utsugi T; Tandon P; Yanagawa H; Okubo A; Ogura T
    Cancer Immunol Immunother; 1990; 30(6):357-62. PubMed ID: 2302725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic therapy for osteosarcoma using liposome-encapsulated muramyl tripeptide.
    Kleinerman ES
    Hematol Oncol Clin North Am; 1995 Aug; 9(4):927-38. PubMed ID: 7490249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ibuprofen on monocyte activation by liposome-encapsulated muramyl tripeptide phosphatidylethanolamine (CGP 19835A): can ibuprofen reduce fever and chills without compromising immune stimulation?
    Fujimaki W; Griffin JR; Kleinerman ES
    Cancer Immunol Immunother; 1993; 36(1):45-51. PubMed ID: 8422667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo effect of doxorubicin combined with liposome-encapsulated muramyl tripeptide on canine monocyte activation.
    Shi F; MacEwen EG; Kurzman ID
    Cancer Res; 1993 Sep; 53(17):3986-91. PubMed ID: 8358727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo production of interleukin-6 induced by muramyl peptides and lipopolysaccharide in normal dogs.
    Shi F; Kurzman ID; MacEwen EG
    Cancer Biother; 1995; 10(4):317-25. PubMed ID: 8590897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposome-encapsulated muramyl tripeptide up-regulates monocyte chemotactic and activating factor gene expression in human monocytes at the transcriptional and post-transcriptional levels.
    Asano T; Matsushima K; Kleinerman ES
    Cancer Immunol Immunother; 1994 Jan; 38(1):16-22. PubMed ID: 8299114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution and fate of free and liposome-encapsulated [3H]nor-muramyl dipeptide and [3H]muramyl tripeptide phosphatidylethanolamine in mice.
    Fogler WE; Wade R; Brundish DE; Fidler IJ
    J Immunol; 1985 Aug; 135(2):1372-7. PubMed ID: 4008926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction and maintenance of monocyte cytotoxicity during treatment with liposomes containing muramyl tripeptide despite tachyphylaxis to the cytokine response.
    Galligioni E; Favaro D; Santarosa M; Quaia M; Spada A; Freschi A; Alberti D
    Clin Cancer Res; 1995 May; 1(5):493-9. PubMed ID: 9816008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal muramyl tripeptide upregulates adhesion molecules on the surface of human monocytes.
    Asano T; McIntyre BW; Bednarczyk JL; Wygant JN; Kleinerman ES
    Oncol Res; 1995; 7(5):253-7. PubMed ID: 8534931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Induction of tumoricidal properties in human monocytes by synergism between interferon-gamma and liposome-entrapped muramyl tripeptide].
    Utsugi T; Sone S; Tandon P; Ogawara M; Shimizu E; Nii A; Nakanishi M; Shono M; Ogura T
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3161-8. PubMed ID: 3096216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposome-encapsulated MTP-PE: a novel biologic agent for cancer therapy.
    Asano T; Kleinerman ES
    J Immunother Emphasis Tumor Immunol; 1993 Nov; 14(4):286-92. PubMed ID: 8280710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of serum tumor necrosis factor-alpha and interleukin-6 activity by liposome-encapsulated muramyl tripeptide-phosphatidylethanolamine (L-MTP-PE) in normal cats.
    Fox LE; King RR; Shi F; Kurzman ID; MacEwen EG; Kubilis PS
    Cancer Biother; 1994; 9(4):329-40. PubMed ID: 7719380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.